Vol 3, No 3 (June 29, 2014): Translational Lung Cancer Research [4th European Lung Cancer Conference (ELCC)]

Original Article

ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation
Niki Karachaliou, Ana Gimenez-Capitan, Ana Drozdowskyj, Santiago Viteri, Teresa Moran, Enric Carcereny, Bartomeu Massuti, Alain Vergnenegre, Filippo de Marinis, Miguel Angel Molina, Cristina Teixido, Rafael Rosell

Original Article

Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the “tolerance” to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice
Silvia Novello, Enrica Capelletto, Diego Cortinovis, Marcello Tiseo, Domenico Galetta, Giuseppe Valmadre, Clelia Casartelli, Simonetta Grazia Rapetti, Antonio Rossi


The focused issue “4th European Lung Cancer Conference (ELCC)” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Paul Van Schil served as the unpaid Guest Editor for the focused issue.